Coherus BioSciences, Inc. - CHRS
About Gravity Analytica
Recent News
- 06.04.2025 - Jefferies Global Healthcare Conference
- 05.30.2025 - Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
- 05.30.2025 - Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics
- 05.27.2025 - TD Cowen 6th Annual Oncology Innovation Summit
- 05.27.2025 - Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
- 05.27.2025 - Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
- 05.20.2025 - HCW BioConnect @ Nasdaq NYC 2025
- 05.12.2025 - Q1 2025 Coherus BioSciences, Inc. Earnings Conference Call
- 05.12.2025 - Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
- 05.12.2025 - Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
Recent Filings
- 05.30.2025 - EX-99.1 EX-99.1
- 05.30.2025 - 8-K Current report
- 05.28.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.15.2025 - SC TO-I/A Tender offer statement by Issuer
- 05.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 05.12.2025 - EX-99.1 EX-99.1
- 05.12.2025 - 8-K Current report
- 05.09.2025 - 4 Statement of changes in beneficial ownership of securities
- 05.09.2025 - 4 Statement of changes in beneficial ownership of securities